Hematopoietic stem cell or progenitor cell transplants (HPC) are used as treatments for many hematological diseases and some non-hematological diseases including autoimmune disorders, solid tumors, and several inherited metabolic and immunodeficiency diseases. Due to the critical timing of transfusion support before, during and after HPC transplants, hospitals must develop safe and effective transfusion protocols to support these transplant patients. The purpose of this audioconference lecture is to review these protocols and special blood product requirements, criteria for selection of donor and recipients with emphasis on ABO/Rh(D) and red blood cell antigens, and immunological consequences following transplant including hemolytic reactions. The program will also be given to address any long-term transfusion needs following HPC transplants.

*CT Program

You will have the ability to purchase CD-ROMs of this Audioconference 2 weeks after the session has been presented. For any questions, please contact MultiviewMediaSupport@multiview.com.